Litcius/Paper detail

A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant

Zezhong Liu, Jasper Fuk‐Woo Chan, Jie Zhou, Meiyu Wang, Qian Wang, Guangxu Zhang, Wei Xu, Kenn Ka‐Heng Chik, Yilong Zhang, Youchun Wang, Kwok‐Yung Yuen, Lu Lu, Shibo Jiang

2022Cell Research32 citationsDOIOpen Access PDF

Topics & Concepts

BiologyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibodyAntibody responseCoronavirus disease 2019 (COVID-19)Antibody2019-20 coronavirus outbreakImmunologyVirusInfectious disease (medical specialty)DiseaseOutbreakMedicinePathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant | Litcius